Though researchers are learning more every day about the coronavirus, Dr. Adams says patients with blood cancers such as leukemia, lymphoma and myelodysplastic syndromes are likely among those at greatest risk for complications from coronavirus. That’s because the blood system is central to immune function.
But any patient actively battling cancer or receiving immune-suppressing treatments, including chemotherapy, could have an elevated risk of complications from coronavirus, she says.
Cancer survivors, especially those who have been in remission for more than a few months, are probably not at significantly increased risk compared to their peers, she says.
And, she says, it’s important to note that breast cancer patients and survivors who receive hormone-blocking therapy are not considered immunocompromised.